Cipralisant (GT-2331 tentative trade name Perceptin) is an extremely potent Histamine H3 receptor ligand originally developed by Gliatech. Cipralisant was initially classified as a selective H3 antagonist but newer research (2005) suggests also agonist properties i. e. functional selectivity.
This page contains content from the copyrighted Wikipedia article "Cipralisant"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
-Cipralisante_Structural_Formulae.png?width=300)